Did you miss "Mad Money" on CNBC? If so, here are some of Jim Cramer's top takeaways.
Not every winner in this red-hot market is a tech stock, Cramer reminded viewers. Most of this market's winners are, in fact, boring companies delivering slow and steady growth.
Case in point: three medical stocks Cramer deemed the "Killer Bs," Baxter International Inc. (BAX - Get Report) , Becton Dickinson and Co. (BDX - Get Report) and Boston Scientific Corp. (BSX - Get Report)
So far in 2017, shares of Baxter are up 36%, Becton up 22% and Boston Scientific are higher by 23%. Taking a longer, five-year view, the gains are even more impressive, with Boston Scientific up a stunning 400%.
How are these companies able to post such returns? Cramer said they have America's aging demographics pulling in their favor, but they also have rapid innovation, introducing both new products as well as improvements to existing ones.
Despite all their positives, shares still trade at a respectable 23 times earnings for Baxter and just 19 times for the other two. That's more than reasonable given these companies' growth rates, Cramer concluded.
On Real Money, Cramer says that he believes expectations have simply gotten too high going into the reporting period for the transports. Get his insights on rails, freight and airlines with a free trial subscription to Real Money.
Cramer and the AAP team are giving their investment club members some insight on this week's earnings, including Apple (AAPL - Get Report) , Magellan Midstream Partners (MMP - Get Report) , and NXP Semiconductors, (NXPI - Get Report) . Get in on the conversation with a free trial subscription to Action Alerts PLUS.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.